Education
About Us
Working with TipRanks
Follow Us
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ -1.12M | $ -73.00K |
| Operating Income | $ -55.26M | $ -13.46M | $ -14.01M | $ -169.82M | $ -71.31M |
| EBITDA | $ -58.77M | $ -14.01M | $ -15.25M | $ -169.84M | $ -69.71M |
| Net Income | $ -58.77M | $ -14.70M | $ -15.48M | $ -171.96M | $ -69.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 118.29M | $ 3.17M | $ 3.06M | $ 248.12M | $ 356.32M |
| Total Assets | $ 118.55M | $ 3.33M | $ 3.90M | $ 286.59M | $ 370.82M |
| Total Debt | $ 0.00 | $ 0.00 | $ 3.25M | $ 30.07M | $ 8.69M |
| Net Debt | $ -118.29M | $ -3.17M | $ 194.00K | $ -171.59M | $ -113.97M |
| Total Liabilities | $ 5.24M | $ 48.35M | $ 34.17M | $ 61.33M | $ 17.76M |
| Stockholders' Equity | $ 113.31M | $ -45.02M | $ -30.27M | $ 225.27M | $ 353.06M |
| Cash Flow | |||||
| Free Cash Flow | $ -67.70M | $ -14.13M | $ -9.78M | $ -106.34M | $ -61.05M |
| Operating Cash Flow | $ -67.70M | $ -14.13M | $ -9.78M | $ -106.32M | $ -60.81M |
| Investing Cash Flow | $ 95.00M | $ 0.00 | $ 0.00 | $ 185.98M | $ -169.50M |
| Financing Cash Flow | $ 21.00K | $ 14.24M | $ 12.78M | $ 232.00K | $ 291.98M |